“…in Helicobacter pylori and Proteus mirabilis), through to altered production of virulence determinants (e.g. in Porphyromonas gingivalis, Streptococcus pyogenes and Clostridium perfringens), and decreased virulence (in Neisseria meningitidis, Streptococcus pneumoniae and Vibrio vulnificus) (Burgess et al, 2002;Joyce et al, 2000;Kim et al, 2003;Lyon et al, 2001;Ohtani et al, 2002;Schneider et al, 2002;Stroeher et al, 2003;Winzer et al, 2002b). However, the elucidation of the biosynthetic pathway of AI-2 has revealed a metabolic role for LuxS, in the S-adenosylmethionineutilization pathway (Schauder et al, 2001;Winzer et al, 2002a).…”